Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myeloma.
Grossbard, Michael L.; Fidias, Panos; Kinsella, Jeanne; O'toole, John; Lambert, John M.; Blattler, Walter A.; Esseltine, Dixie; Braman, Ginny; Nadler, Lee M.; Anderson, Kenneth C.; British Journal of Haematology, 1998, vol. 102, issue 2, p 509, ISSN 00071048. ISBN 00071048.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef